Status:
COMPLETED
Single Pass Albumin Dialysis in Patients With Cirrhosis
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Collaborating Sponsors:
Laboratoire français de Fractionnement et de Biotechnologies
Institut National de la Santé Et de la Recherche Médicale, France
Conditions:
Cirrhosis
Acute on Chronic Hepatic Failure
Eligibility:
All Genders
18+ years
Phase:
PHASE1
PHASE2
Brief Summary
The aim of this study is to determine whether a simplified device of albumin dialysis also has beneficial effects.
Detailed Description
Albumin dialysis has beneficial effects in patients with acute on chronic liver failure. However, current devices are complex and costly. The aim of this study is to determine whether a simplified dev...
Eligibility Criteria
Inclusion
- Minimum age of 18 years
- Written consent after information of the patient or, in case of inability, by a parent or a close if he is present.
- Patient having a cirrhosis researched by previous exams (liver biopsy) or, in the absence of previous diagnosis, diagnosed in view of the results of clinical, biological and morphological data, whatever the origin of the cirrhosis (virus of hepatitis B, virus of hepatitis C, extreme consumption of alcohol or other reasons)
Exclusion
- Participation to an other study in the 4 weeks before
- Active digestive bleeding, unchecked by the pharmacological treatments and the endoscopic techniques.
Key Trial Info
Start Date :
June 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2012
Estimated Enrollment :
11 Patients enrolled
Trial Details
Trial ID
NCT00764049
Start Date
June 1 2009
End Date
July 1 2012
Last Update
February 25 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Beaujon
Clichy, France, 92110